Last quarter (Q ), OncoSec Medical's total revenue was $―, a decrease of ― from the same quarter last year. In Q, OncoSec Medical's net income was $-6.86M. See OncoSec Medical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jul 22	Jul 21	Jul 20	Jul 19	Jul 18
Total Revenue	-	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 32.65M	$ 37.01M	$ 48.38M	$ 43.41M	$ 30.42M	$ 36.11M
Operating Income	$ -32.65M	$ -37.01M	$ -48.38M	$ -43.41M	$ -30.42M	$ -36.11M
Net Non Operating Interest Income Expense	$ -52.13K	$ -20.93K	$ -15.86K	$ -5.11K	$ -3.81K	$ 0.00
Other Income Expense	$ -841.87K	$ -28.86K	$ 816.00K	$ 288.19K	$ 145.73K	$ -3.03M
Pretax Income	$ -32.72M	$ -37.51M	$ -47.58M	$ -43.13M	$ -30.27M	$ -39.14M
Tax Provision	$ -3.33M	$ -3.33M	$ -2.41M	$ -872.59K	$ 1.30K	$ 680.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -29.39M	$ -34.18M	$ -45.17M	$ -42.25M	$ -30.28M	$ -39.14M
Basic EPS	$ -4.87	-	$ -1.37	$ -2.56	$ -4.29	$ -9.75
Diluted EPS	$ -4.87	-	$ -1.37	$ -2.56	$ -4.29	$ -9.75
Basic Average Shares	$ 80.52M	-	$ 32.90M	$ 16.53M	$ 7.05M	$ 4.01M
Diluted Average Shares	$ 80.52M	-	$ 32.90M	$ 16.53M	$ 7.05M	$ 4.01M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 32.65M	$ -37.01M	$ 48.38M	$ 43.41M	$ 30.42M	$ 36.11M
Net Income From Continuing And Discontinued Operation	$ -29.39M	$ -34.18M	$ -45.17M	$ -42.25M	$ -30.28M	$ -39.14M
Normalized Income	$ -21.65M	-	$ -45.94M	$ -42.35M	$ -29.98M	$ -35.73M
Interest Expense	$ 18.58K	-	$ 15.86K	$ 5.11K	$ 3.81K	$ 0.00
EBIT	$ -32.67M	$ -37.49M	$ -47.56M	$ -43.12M	$ -30.27M	$ -39.14M
EBITDA	$ -31.79M	$ -37.69M	$ -46.49M	$ -42.13M	$ -30.03M	$ -38.80M

Currency in USD

OncoSec Medical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing